Compugen Ltd. (CGEN)

Compugen Ltd. (CGEN) is a healthcare company (biotechnology) based in Israel. The share price is $2.03, down 0.49% on the day, which values the company at $192.29M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$2.03−0.49% today
Market value
$192.29M
P/E ratio
5.2×last 12 months
Funk Score
83/100
Against its own history
Well below its usual priceusual price $15.21
200-week average
$1.6920% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Compugen Ltd. in more detail

CGEN trades at 5.2× its last twelve months' earnings, -5.8× next year's expected earnings, 2.5× sales. Measured against its own history, the price is 87% below what its usual multiples would imply ($15.21) — well below its usual price. It sits 20% above its 200-week average of $1.69.

Over the last five fiscal years Compugen Ltd. has compounded revenue 105.2% a year. Its Funk Score is 83 out of 100 (financial strength 6.9, profitability 7.8, growth 9.3, value 9.3, each out of 10).

In its favour: Strong Piotroski score; More cash than debt. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

1 of the superinvestors tracked here hold CGEN, including Cathie Wood (0.0% of the portfolio).

Superinvestors holding CGEN

1 of the investors tracked here report a position in their latest 13F filing.

Compugen Ltd. (CGEN): questions and answers

What is CGEN's P/E ratio?

Compugen Ltd. trades at 5.2× its last twelve months' earnings and -5.8× next year's expected earnings.

What is CGEN's PEG ratio?

Compugen Ltd.'s PEG ratio is 1.29 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Compugen Ltd.'s market cap?

Compugen Ltd. is valued at $192.29M at a share price of $2.03.

Is CGEN overvalued or undervalued?

Against its own history, CGEN is well below its usual price: the price is 87% below the $15.21 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is CGEN above its 200-week moving average?

Yes. CGEN is 19.8% above its 200-week average of $1.69. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Compugen Ltd. growing?

Over the last five fiscal years Compugen Ltd.'s revenue grew 105.2% a year; over ten years revenue grew 22.9% a year.

Cite this page

Funkfolio, “Compugen Ltd. (CGEN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CGEN

Underlying data: Yahoo Finance; company filings with the SEC.